KLOW 80 (80mg)

KLOW 80 (80mg): Product Description

KLOW 80 is a multi-component research blend containing GHK‑Cu, KPV, BPC‑157 and TB‑500. identifies the composition as 50 mg of GHK‑Cu, 10 mg of KPV, 10 mg of BPC‑157 and 10 mg of TB‑500, producing a total nominal content of 80 mg.

Each component retains its own molecular identity. Consequently, KLOW 80 does not have one unified molecular formula, molecular weight or CAS number. Laboratory research involving this blend may examine extracellular-matrix signaling, copper-peptide interactions, inflammatory-response pathways, cellular migration, angiogenic signaling and tissue-model repair mechanisms.

GHK‑Cu is a copper-binding tripeptide complex. KPV is a short three-amino-acid fragment associated with alpha-melanocyte-stimulating hormone research. BPC‑157 is a synthetic 15-amino-acid peptide, while TB‑500 is a name used commercially for thymosin beta‑4-associated research material.

The exact identity of the TB‑500 component should be confirmed through the Certificate of Analysis because the term may refer either to full-length thymosin beta‑4 or a related fragment. lists the blend at a purity of at least 99% by HPLC.

Research Specifications

GHK‑Cu — 50 mg

Molecular Formula: Commonly represented as C14H22CuN6O4

Compound Type: Copper-binding tripeptide complex

KPV — 10 mg

Molecular Formula: C16H30N4O4

Sequence: Lys-Pro-Val

BPC‑157 — 10 mg

Molecular Formula: C62H98N16O22

Molecular Weight: Approximately 1,419.5 g/mol

Amino Acid Count: 15

TB‑500 — 10 mg

Molecular identity depends on whether the material is full-length thymosin beta‑4 or a related fragment

Full-length Thymosin Beta‑4 is commonly represented as C212H350N56O78S

COA verification required

Total Presentation: 80 mg

For Research Use Only. Not for human or animal consumption. Not intended for diagnostic or therapeutic use.